The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
Insulin resistance is an underappreciated facet of type 1 diabetes that occurs with remarkable consistency and considerable magnitude. Although therapeutic innovations are continuing to normalize dysglycemia, a sizable body of data suggests a second metabolic abnormality—iatrogenic hyperinsulinemia—principally drives insulin resistance and its consequences in this population and has not been addressed. We review this evidence to show that injecting insulin into the peripheral circulation bypasses first-pass hepatic insulin clearance, which leads to the unintended metabolic consequence of whole-body insulin resistance. We propose restructuring insulin therapy to restore the physiological insulin balance between the hepatic portal and peripheral circulations and thereby avoid the complications of life-long insulin resistance. As technology rapidly advances and our ability to ensure euglycemia improves, iatrogenic insulin resistance will become the final barrier to overcome to restore normal physiology, health, and life in type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In fact, the improvement of glycemic control through SC insulin delivery does not come without a cost: individuals with T1D are exposed to peripheral nonphysiologic hyperinsulinemia that, over time, is a major contributor to macrovascular complications, including heart failure and macrovascular disease”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“that are still 3 times more frequent in those with T1D respect to their healthy peers (see Gregory 139 also for pertinent literature review).”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [139]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964
Berson, S. A., Yalow, R. S., Bauman, A., Rothschild, M. A., & Newerly, K. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103262 · Cited by 836
Insulin Resistance and Hyperinsulinemia
Shanik, M. H., Xu, Y., Škrha, J., Dankner, R., Zick, Y., & Roth, J. (2008) · Diabetes Care · doi:10.2337/dc08-s264 · Cited by 791
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) · Diabetes Care · doi:10.2337/dc15-1990 · Cited by 712
The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes
Wilkin, T. J. (2001) · Diabetologia · doi:10.1007/s001250100548 · Cited by 623 · cited 1×
“” These concepts posit that coexisting b-cell immune intolerance and insulin resistance related to increased weight work in concert to accelerate b-cell loss and thwart insulin therapy in type 1 diabetes (68,69).”
BackgroundWeinzimer, S. A., Steil, G. M., Swan, K. L., Dziura, J., Kurtz, N., & Tamborlane, W. V. (2008) · Diabetes Care · doi:10.2337/dc07-1967 · Cited by 567
DeFronzo, R. A., Simonson, D., & Ferrannini, E. (1982) · Diabetologia · doi:10.1007/bf00253736 · Cited by 541
Orchard, T. J., Olson, J. C., Erbey, J. R., Williams, K., Forrest, K. Y.-Z., Smithline Kinder, L., Ellis, D., & Becker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1374 · Cited by 492 · cited 1×
“Epidemiologic data from the Pittsburgh Epidemiology of Diabetes Complications study (21) and observational data from the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study (13,22) have linked insulin resistance independently with cardiovascular disease, which remains the major lifelimiting complication of…”
Method
Research works printed but not linked: 1
- Valcarce, 2019, Results from the sentinel and learning phase of the Simplici-T1 study, the first clinical trial to test activation of glucokinase as an adjunctive treatment for type 1 diabetes, Diabetologia, 62, 1
Cited by
Hyperinsulinemia in Obesity, Inflammation, and Cancer
Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0250 · Cited by 305
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery
Sherr, J. L., Schoelwer, M., Dos Santos, T. J., Reddy, L., Biester, T., Galderisi, A., van Dyk, J. C., Hilliard, M. E., Berget, C., & DiMeglio, L. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13421 · Cited by 152
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Apostolopoulou, M., Lambadiari, V., Roden, M., & Dimitriadis, G. D. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnae032 · Cited by 90
Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis
Lambie, M., Bonomini, M., Davies, S., Accili, D., Arduini, A., & Zammit, V. A. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.06.001 · Cited by 90
Diabetes pathogenesis and management: the endothelium comes of age
Love, K. M., Barrett, E. J., Malin, S. K., Reusch, J. E. B., Regensteiner, J. G., & Liu, Z. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab024 · Cited by 57
An overview of oral insulin delivery strategies (OIDS)
Iyer, G., Dyawanapelly, S., Jain, R. D., & Dandekar, P. P. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.144 · Cited by 57
Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility
Cobelli, C., & Kovatchev, B. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231195081 · Cited by 46
Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320
Kjeldsen, T., Hubálek, F., Tagmose, T. M., Pridal, L., Refsgaard, H. H. F., Porsgaard, T., Gram-Nielsen, S., Hovgaard, L., Valore, H., Münzel, M., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01576 · Cited by 45
Karamanakos, G., Kokkinos, A. D., Dalamaga, Μ., & Liatis, S. (2022) · Current Obesity Reports · doi:10.1007/s13679-022-00477-x · Cited by 49
Current Management of Glycemia in Children with Type 1 Diabetes Mellitus
Sperling, M. A., & Laffel, L. M. (2022) · New England Journal of Medicine · doi:10.1056/nejmcp2112175 · Cited by 43
Alfatama, M., Choukaife, H., Alkhatib, H., Rahal, O. A., & Zin, N. Z. M. (2024) · Nanotechnology Reviews · doi:10.1515/ntrev-2023-0205 · Cited by 44
Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial
SNAITH, J. R., Frampton, R., Samocha‐Bonet, D., & Greenfield, J. R. (2025) · Diabetes Care · doi:10.2337/dc25-2379 · Cited by 51
Krinsley, J. S., Rule, P. R., Roberts, G. W., Brownlee, M., Preiser, J., Chaudry, S., Dionne, K. D., Heluey, C., Umpierrez, G. E., & Hirsch, I. B. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005490 · Cited by 34
Autoimmune diseases: targets, biology, and drug discovery
Li, S.-J., Wu, Y., Chen, J.-H., Shen, S.-Y., Duan, J., & Xu, H. E. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01207-2 · Cited by 41
Importance of the route of insulin delivery to its control of glucose metabolism
Edgerton, D. S., Moore, M. C., Gregory, J. M., Kraft, G., & Cherrington, A. D. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00628.2020 · Cited by 31
Self-citationGlycemic control in critically ill patients with or without diabetes
Fong, K. M., Au, S. Y., & Ng, G. W. Y. (2022) · BMC Anesthesiology · doi:10.1186/s12871-022-01769-4 · Cited by 29
Estimated insulin sensitivity in Type 1 diabetes adults using clinical and research biomarkers
Januszewski, A. S., Sachithanandan, N., Ward, G., Karschimkus, C. S., O'Neal, D. N., & Jenkins, A. J. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108359 · Cited by 24
Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?
Resnick, O., Bril, F., & Beauchamp, G. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1520313 · Cited by 27
Infante, M., Silvestri, F., Padilla, N., Pacifici, F., Pastore, D., Pinheiro, M. M., Caprio, M., Tesauro, M., Fabbri, A., Novelli, G., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041303 · Cited by 20
Sammut, M. J., Dotzert, M. S., & Melling, C. W. J. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31419 · Cited by 19
Frampton, R., SNAITH, J. R., HOCKING, S. L., Holmes-Walker, D. J., Olsen, N., & Greenfield, J. R. (2024) · Diabetic Medicine · doi:10.1111/dme.15377 · Cited by 15
Promises and pitfalls of beta cell–replacement therapies
Kolic, J., & Johnson, J. D. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00433-4 · Cited by 11
Vergani, M., Borella, N. D., Rizzo, M., Conti, M., Perra, S., Bianconi, E., Sani, E., Csermely, A., Grespan, E., Targher, G., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16333 · Cited by 16
Sweeteners: erythritol, xylitol and cardiovascular risk—friend or foe?
Wölnerhanssen, B. K., Meyer‐Gerspach, A. C., Arduini, A., D’Alessandro, A., Gronda, E., Carugo, S., Bonomini, M., Gallieni, M. A., Masola, V., Angelillo‐Scherrer, A., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf091 · Cited by 14
SNAITH, J. R., Samocha‐Bonet, D., Evans, J., Liu, Z., Kowalski, G. M., Bruce, C. R., Holmes-Walker, D. J., & Greenfield, J. R. (2021) · Diabetic Medicine · doi:10.1111/dme.14564 · Cited by 13
Krinsley, J. S., Rule, P., Brownlee, M., Roberts, G., Preiser, J., Chaudry, S., Dionne, K., Heluey-Rodrigues, C., Umpierrez, G. E., & Hirsch, I. B. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211032277 · Cited by 11
Gao, T., Chen, S., Han, Y., Zhang, D., Tan, Y., He, Y., & Liu, M. (2022) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-022-01085-1 · Cited by 12
SNAITH, J. R., Narongkiatikhun, P., Bjornstad, P., Greenfield, J. R., & Tommerdahl, K. L. (2025) · Diabetes Care · doi:10.2337/dci25-0015 · Cited by 19
SNAITH, J. R., Olsen, N., Evans, J., Kowalski, G. M., Bruce, C. R., Samocha‐Bonet, D., Breit, S. N., Holmes-Walker, D. J., & Greenfield, J. R. (2025) · Nature Communications · doi:10.1038/s41467-025-65951-1 · Cited by 10
Martyushev-Poklad, A. V., Yankevich, D. S., Petrova, M. V., & Savitskaya, N. G. (2022) · Problems of Endocrinology · doi:10.14341/probl13090 · Cited by 18
Insulin-mediated muscle microvascular perfusion and its phenotypic predictors in humans
Love, K. M., Jahn, L. A., Hartline, L. M., Patrie, J. T., Barrett, E. J., & Liu, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-90935-8 · Cited by 8
Kraft, G., Coate, K. C., Smith, M. S., Farmer, B., Scott, M. F., Cherrington, A. D., & Edgerton, D. S. (2021) · Diabetes · doi:10.2337/db20-1271 · Cited by 11
Self-citationBruce, C. R., Ang, T., Toms, J. D., Dao, G. M., Liu, J., Ward, G. M., O'Neal, D. N., Morrison, D., & Kowalski, G. M. (2024) · Diabetes · doi:10.2337/db24-0388 · Cited by 9
Elkhwanky, M., Kummu, O., & Hakkola, J. (2022) · Endocrinology · doi:10.1210/endocr/bqac060 · Cited by 5
Kraft, G., Coate, K. C., Smith, M. S., Farmer, B., Scott, M. F., Hastings, J. R., Cherrington, A. D., & Edgerton, D. S. (2022) · Diabetes · doi:10.2337/db22-0471 · Cited by 6
Self-citationChange in Body Mass Index in Youth in the First 5 Years After Type 1 Diabetes Mellitus Diagnosis
Ganta, A., Warnick, J. L., Has, P., Gonzalez, M. S., Fredette, M. E., & Topor, L. S. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.05.003 · Cited by 5
Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes
Raven, L. M., Greenfield, J. R., & Muir, C. A. (2022) · JCEM Case Reports · doi:10.1210/jcemcr/luac017 · Cited by 6
Kabubii, Z. N., Mbaria, J. M., Mathiu, P. M., Wanjohi, J. M., & Nyaboga, E. N. (2024) · Clinical Phytoscience · doi:10.1186/s40816-024-00378-7 · Cited by 8
Sammut, M. J., McBey, D. P., Sayal, A. P., & Melling, C. W. J. (2024) · Journal of Diabetes Research · doi:10.1155/2024/5549762 · Cited by 6
Targeting cardiometabolic risk in type 1 diabetes through incretin physiology
Frampton, R., HOCKING, S. L., SNAITH, J. R., & Greenfield, J. R. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.06.004 · Cited by 4
Metabolic Dysfunction-Associated Steatotic Liver Disease in People with Type 1 Diabetes
Vermillion, B., & Mao, Y. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155502 · Cited by 4
Tissue engineering approaches and generation of insulin-producing cells to treat type 1 diabetes
Khazaei, M., Khazaei, F., Niromand, E., & Ghanbari, E. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2107653 · Cited by 6
Guimarães, J. P. T., Menikdiwela, K. R., Ramalho, T. R. D. O., Queiroz, L. A. D., Kalupahana, N. S., Jancar, S., Ramalingam, L., Martins, J. O., & Moustaïd‐Moussa, N. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166477 · Cited by 4
Gooch, A. M., Chowdhury, S., Zhang, P. M., Hu, Z., & Westenfelder, C. S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290460 · Cited by 3
Shao, X., Fur, S. L., Cheung, W., Belot, M., Perge, K., Bouhours‐Nouet, N., Bensignor, C., Levaillant, L., Ge, B., Kwan, T., et al. (2025) · Scientific Reports · doi:10.1038/s41598-024-82698-9 · Cited by 4
Waterman, H. L., Moore, M. C., Smith, M. S., Farmer, B., Yankey, K. C., Scott, M. F., Edgerton, D. S., & Cherrington, A. D. (2024) · Diabetes · doi:10.2337/db24-0786 · Cited by 3
Self-citationRecent advances and perspectives in novel insulin release systems
Barkhordari, S., Samandari, S. S., Abdouss, M., & Pourmadadi, M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106500 · Cited by 2
Insulin Resistance in Experimental Type 1 Diabetes Mellitus
Ivanov, V. V., Buyko, E. E., Ufandeev, A. A., Nevskaya, K. I., Удут, В. В., Zima, A. P., Саприна, Т. В., & Udut, E. V. (2022) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-022-05458-7 · Cited by 2
Reducing Caretaker Burden, Protecting Young Brains and Bodies
Levitsky, L. L. (2022) · New England Journal of Medicine · doi:10.1056/nejme2119915 · Cited by 2
Waterman, H. L., Smith, M. S., Farmer, B., Yankey, K. C., Howard, T., Kraft, G., Cherrington, A. D., & Edgerton, D. S. (2026) · Diabetes · doi:10.2337/db26-0103 · Cited by 1
Self-citationOliver, N. S., Gehr, B., Lal, R., van Dijk, P. R., & Renard, É. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71054 · Cited by 1
Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes
Zoppini, G., Bergamini, C., Trombetta, M., Mantovani, A., Targher, G., Toffalini, A., Bittante, C., & Bonora, E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244483 · Cited by 1
Januszewski, A. S., & Jenkins, A. J. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_18-1 · Cited by 1
Januszewski, A. S., & Jenkins, A. J. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_18 · Cited by 1
Lezhenko, G. O., Pashkovа, O. Y., & Chudova, N. I. (2022) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2022.6.261182 · Cited by 1
Cipponeri, E., Tarsitano, M. G., Falbo, E., & Conte, C. (2025) · Discover Endocrinology and Metabolism · doi:10.1007/s44417-025-00010-3 · Cited by 1
Inhalation of Insulin for Diabetes Management
Bahman, F., & Taurin, S. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165498-00165 · Cited by 1
Waterman, H. L., Moore, M. C., Smith, M. S., Farmer, B., Yankey, K. C., Scott, M. F., Edgerton, D. S., & Cherrington, A. D. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.25.614969 · Cited by 1
Self-citationGao, T., Chen, S., Han, Y., Tan, Y., Zhang, D., He, Y., & Liu, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1567997/v1
Januszewski, A. S., & Jenkins, A. J. (2023) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_18-2
3D Organoids of Mesenchymal Stromal and Pancreatic Islet Cells
Westenfelder, C. S., & Gooch, A. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_9
The cross-talk between autoimmune diseases and sarcopenia (Preprint)Preprint
Gao, Y., Zhang, Y., Wu, Q., Chen, Q., Wang, Y., Li, B., Zhao, Q., Wang, Q., Wang, Y., & Han, S. (2024) · doi:10.2196/preprints.64456
Camenzuli, J., Sammut, M. J., Tijo, T., & Melling, C. W. J. (2025) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2024-0226
Januszewski, A. S., SNAITH, J. R., Grzelka‐Woźniak, A., Simonsen, J. R., Sachithanandan, N., Ward, G. M., O'Neal, D. N., Gordin, D., Thorn, L. M., Groop, P., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16487
Case Report: Insulin resistance in type 1 diabetes mellitus: the role of genetic factors
Wei, J., Lu, S., & Zhang, T. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1656453
Additional file 2 of Glycemic control in critically ill patients with or without diabetes
Fong, K. M., Au, S. Y., & Ng, G. W. Y. (2022) · Figshare · doi:10.6084/m9.figshare.20329806
Additional file 1 of Glycemic control in critically ill patients with or without diabetes
Fong, K. M., Au, S. Y., & Ng, G. W. Y. (2022) · Figshare · doi:10.6084/m9.figshare.20329803
Januszewski, A. S., SNAITH, J. R., Kowalski, G. M., Bruce, C. R., Holmes-Walker, D. J., Jenkins, A. J., & Greenfield, J. R. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70517 · Cited by 1
Akbar, M. N., Smith, T. J., Chinnarasu, S., Welch, W., Zuofei, W., Litts, B., LeStourgeon, L. M., Saleem, M., Khan, M. M., Kirabo, A., et al. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00276-6
Self-citationCortes, J. A. P., Narongkiatikhun, P., Snethlage, C. M. F., Castillo, D. D., Tommerdahl, K., Nadeau, K., & Bjornstad, P. (2026) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/j.ecl.2026.04.008
Gabbay, U., & Carmi, D. (2026) · Obesity Medicine · doi:10.1016/j.obmed.2026.100722
Hu, L., Wang, F., Shang, J., Chen, X., Lei, Y., Zhu, X., Deng, X., Wei, Y., & Zhang, J. (2026) · Applied Food Research · doi:10.1016/j.afres.2026.102504
Myosteatosis in type 1 diabetes: immunometabolic mechanisms, biomarkers, and therapeutic targets
Al‐Rashed, F., AlSaeed, H., Fennelly, K. P., Mulla, F. A., & Ahmad, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1900161
Type 1 diabetes and cardiovascular medicine
Jenkins, A. J., Huang, M., Hemphill, M., Chen, D., Ha, J. T., Sata, Y., Sindone, A. P., Gnanenthiran, S. R., & Lan, N. S. R. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00338-9
Perspectives on tissue-selective insulin derivatives
Hejl, M., & Jiráček, J. (2026) · Open Biology · doi:10.1098/rsob.260175
Metadata
- Authors
- Gregory, J. M., Cherrington, A. D., & Moore, D. J.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Gregory, Justin M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-04-13
- Volume
- 69
- Issue
- 5
- Pages
- 837-847
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC7171956
- OpenAlex
- W3016704539
- Cited by
- 76
- References
- 93
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 11 · 2023: 5 · 2022: 23 · 2021: 9 · 2020: 3
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD087023)
- Wallace Family Fund in Diabetes Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 1 diabetes, insulin resistance, insulin therapy, hepatic insulin clearance, normoglycemia
- MeSH terms
- Animals, Diabetes Mellitus, Type 1, Gene Expression Regulation, Humans, Insulin, Insulin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.